Variability in Golimumab Exposure: A ‘Real-Life’ Observational Study in Active Ulcerative Colitis

201675 citationsJournal Articlebronze Open Access

Authors

Adequate exposure to golimumab drives clinical response. A worse disease at baseline influences clinical response rate negatively.

Published in: Journal of Crohn s and Colitis

Volume 10, Issue 5, pp. 575-581

Field-Weighted Citation Impact: 13.81